Extracellular matrix scaffold technology for bioartificial pancreas engineering: state of the art and future challenges
M Salvatori, R Katari, T Patel, A Peloso… - Journal of diabetes …, 2014 - journals.sagepub.com
Emergent technologies in regenerative medicine may soon overcome the limitations of
conventional diabetes therapies. Collaborative efforts across the subfields of stem cell …
conventional diabetes therapies. Collaborative efforts across the subfields of stem cell …
Perfusion-decellularized pancreas as a natural 3D scaffold for pancreatic tissue and whole organ engineering
Approximately 285 million people worldwide suffer from diabetes, with insulin
supplementation as the most common treatment measure. Regenerative medicine …
supplementation as the most common treatment measure. Regenerative medicine …
Porcine pancreas extracellular matrix as a platform for endocrine pancreas bioengineering
Emergent technologies of regenerative medicine have the potential to overcome the
limitations of organ transplantation by supplying tissues and organs bioengineered in the …
limitations of organ transplantation by supplying tissues and organs bioengineered in the …
Bio-engineered pancreas with human embryonic stem cells and whole organ derived extracellular matrix scaffolds
SK Goh - 2015 - search.proquest.com
Abstract According to Centers of Disease Control (CDC), 25.8 million Americans were
diagnosed with diabetes in 2010, and more than 300 million people were affected …
diagnosed with diabetes in 2010, and more than 300 million people were affected …